Drug cards DC1-DC6 Spring 2025: FDA indications and dosages

FDA indications/Dosages for Actos

As an adjunct to diet and exercise in improving type 2 diabetes. Start with 15-30 mg given once daily.

FDA indications/Dosages for Sitagliptin Phosphate and Metformin HCl

As an adjunct to diet and exercise to improve type 2 diabetes. One tablet twice a day with meals or 1 extended release tablet daily.

FDA indications/Dosages for Farxiga

As an adjunct to diet and exercise to improve type 2 diabetes. Take 1 tablet once daily in the morning

FDA indications/Dosages for Empagliflozin

As an adjunct to diet and exercise to improve type 2 diabetes. Recommended starting dose is 10 mg once daily in the morning.

FDA indications/Dosages for Invokana

As an adjunct to diet and exercise to improve type 2 diabetes. Start with 100 mg before the first and last meal of the day.

FDA indications/Dosages for Tradjenta

As an adjunct to diet and exercise to improve type 2 diabetes. Take one 5 mg once daily.

FDA indications/Dosages for Sitagliptin

As an adjunct to diet and exercise to improve type 2 diabetes. Normal adult dose is 100 mg once daily

FDA indications and dosages for Liraglutide

As adjunct to diet and exercise to improve type 2 diabetes. One dose administered once daily by subcutaneous injection.

FDA indications and dosages for Ozempic

As an adjunct to diet and exercise to improve type 2 diabetes and to reduce the risk of major adverse cardiovascular events in adults. Recommended dose is starting with 0.25 mg one weekly for 4 weeks

FDA indications/Dosages for Dulaglutide

As an adjunct to diet and exercise to improve type 2 diabetes. Usual maintenance dose is 0.75-1.5 mg once weekly

FDA indications/Dosages for Insulin Lispro

Treatment of type 1 or type 2 diabetes, that cannot be controlled through diet, exercise, or weight reduction. Dosage must be individualized

FDA indications/Dosages for Tresiba

To improve glycemic control in adults with diabetes. Dosage must be individualized.

FDA indications/Dosages for Novolog

Treatment of type 1 or type 2 diabetes that cannot be properly controlled with diet, exercise, or weight reduction. Dosage must be individualized.

FDA indications/Dosages for Levemir

For the treatment of adult and pediatric patients with type 1 diabetes or adult patients with type 2 diabetes who require basal (long acting) insulin for hyperglycemia. Dosage must be individualized.

FDA indications/Dosages for Ezetimibe

For adjunct therapy to diet for the reduction of elevated LDL, and total cholesterol in patients with familial hypercholesterolemia alone or in combination to other HMG-reductase inhibitors or fenofibrate. Recommended daily dose for all indications is 10 mg.

FDA indications/Dosages for Niacin (ER)

As an adjunct to diet for the reduction of elevated total cholesterol, LDL-C, ApoB, and TG levels and to increase HDL in patients with hypercholesterolemia. Reduce the risk of heart attack, slow the regression of atherosclerosis, and as adjunct therapy for the treatment of high serum triglyceride levels to patients with pancreatitis who don't respond to diet changes. Start with 500 mg at bedtime for 4 weeks.

FDA indications/Dosages for Lovaza

As adjunct to diet to reduce triglyceride (TG) levels in adult patients with very high TG levels. Normal daily dose is 4 grams (4 capsules) daily given in 1-2 doses

FDA indications/Dosages for Vascepa

As an adjunct to maximally tolerated statin therapy to reduce the risk of heart attack, stroke, coronary revascularization, and unstable angina requiring hospitalization in adult patients with elevated TG levels, diabetes, or cardiovascular disease. Recommended dose is 2 grams given twice daily with food

FDA indications/Dosages for Gemfibrozil

Treatment of patients with type IV or V hyperlipidemia who present a risk of pancreatitis and who do not respond to diet. Reduction of coronary heart disease risk in patients with low HDL levels and high LDL levels that do not respond to changes in diet, exercise, or other medications. Recommended dose is 600 mg given twice daily 30 minutes prior to morning and evening meals.

FDA indications/Dosages for Colestipol HCl

Adjunctive therapy to diet for the reduction of elevated serum total cholesterol and LDL in patients with primary hypercholesterolemia who don't respond to dietary changes. Start with 2 grams once or twice daily.

FDA indications/Dosages for Fenofibrate

As adjunctive therapy to diet to reduce elevated LDL, total cholesterol, TG, and ApoB and to increase HDL in adult patients with hypercholesterolemia, as adjunctive therapy to diet for the treatment of hypertriglyceridemia, and renal impairment. Recommended dose is 145 mg daily with meals.

FDA indications/Dosages for Cholestyramine Resin

As an adjunct to diet for the treatment of primary hypercholesterolemia and for the relief of pruritis associated with partial biliary obstruction. One packet or scoopful (4 grams), mixed in 2-6 oz of water taken 1-6 times daily.

FDA indications/Dosages for Lactulose

For the treatment of constipation. Recommended dose is 10-20 gm per day

FDA indications/Dosages for Linzess

For the treatment of IBS with constipation. Recommended dose is 290 mcg once daily on an empty stomach. Also for the treatment of chronic idiopathic constipation, recommended dose is 145 mcg once daily on an empty stomach.

FDA indications/Dosages for Lansoprazole

For the short-term treatment of active duodenal ulcer, treatment of gastric ulcer, short-term treatment of erosive esophagitis, maintenance of healing for gastric ulcers and erosive esophagitis, and for the treatment of GERD. Recommended dose is 30 mg daily.

FDA indications/Dosages for Dexilant

For the treatment of heartburn associated with GERD, maintain healing of erosive esophagitis, and to heal all grades of erosive esophagitis. Recommended dose is 30 mg once daily.

FDA indications/Dosages for Pantoprazole

For the short term treatment of erosive esophagitis associated with GERD, maintenance of healing from erosive esophagitis, and for the treatment of pathological hypersecretory conditions like Zollinger-Ellison syndrome. Recommended dose is 40 mg taken once daily for up to 8 weeks.

FDA indications/Dosages for Nexium

For the short-term treatment of erosive esophagitis, treatment of GERD, maintenance of healing for erosive esophagitis, as an adjunct in the Triple Therapy for H.Pylori infection, for the reduction in the occurrence of gastric ulcers, and for the treatment of pathological hypersecretory conditions like Zollinger-Ellison syndrome. Recommended dose is 20-40 mg daily for 4-8 weeks.

FDA indications/Dosages for Carafate

For the short term (4-8 weeks) treatment of duodenal ulcer, and for the maintenance of duodenal ulcer. Recommended dose is 1 gram 4 times a day on an empty stomach

FDA indications/Dosages for Baclofen

For the signs and symptoms of spasticity resulting from MS, particularly for the relief of flexor spasms and concomitant pain, clonus, and muscular rigidity. Recommended dose is 10-20 mg given three to four times daily.

FDA indications/Dosages for Tizanidine HCl

For the short-term management of spasticity. Starts with 4 mg given every 6-8 hrs.

FDA indications/Dosages for Cyclobenzaprine HCl

Relief of skeletal muscle spasm associated with acute, painful musculoskeletal conditions. Recommended dose is 10 mg three times daily.

FDA indications/Dosages for Robaxin

As an adjunct to rest, physical therapy, and other measures for the relief of discomforts associated with acute, painful musculoskeletal conditions, and an adjunct to conventional therapy in the treatment of tetanus. Maintenance dose is 750-1000 mg four times daily.

FDA indications/Dosages for Soma

For the relief of of discomfort associated with acute painful musculoskeletal conditions. Recommended dose is 250-350 mg three times daily and at bedtime.

FDA indications/Dosages for Symmetrel

Treatment of idiopathic Parkinson's disease, postencephalitic parkinsonism, symptomatic parkinsonism following carbon monoxide poisoning and drug-induced extrapyramidal reactions, and for uncomplicated respiratory tract illnesses caused by influenza A. Recommended dose is 100 mg given twice daily.

FDA indications/Dosages for Sinemet

For the treatment of the symptoms of idiopathic Parkinson's disease, postencephalitic parkinsonism, and symptomatic parkinsonism which may follow injury to the nervous system form CO poisoning or manganese intoxication. Therapy should be individualized and adjusted according to the desired therapeutic response.

FDA indications/Dosages for Pramipexole

For the treatment of the signs and symptoms of idiopathic Parkinson's disease. For the treatment of moderate-severe primary restless leg syndrome (RLS). Maintenance doses range from 0.75 mg- 4 mg daily

FDA indications/Dosages for Ropinirole HCl

For the treatment of the signs and symptoms of idiopathic Parkinson's disease. For the treatment of moderate-severe primary restless leg syndrome (RLS). Normal dosage range is 0.5-5 mg three times daily.

FDA indications/Dosages for Zyloprim

Treatment of gout, prevention of uric acid nephropathy in patients undergoing vigorous neoplastic disease, prevention of acute gouty arthritis flare-up, secondary hyperuricemia associated with cancer, and treatment of recurrent calcium oxalate stones. Recommended dose is 200-300 mg per day.

FDA indications/Dosages for Colchicine

For the treatment and relief of pain in attacks of acute gouty arthritis, and for the prophylaxis of acute gouty arthritis. Recommended dose is 1 tablets every hour or 2 tablets every two hours until pain subsides or until diarrhea/abdominal discomfort ensues.

FDA indications/Dosages for Chantix

As an aid in the cessation of smoking. Recommended dose is 1 mg twice a day

FDA indications/Dosages for Benzonatate

For the symptomatic relief of cough. Recommended dose is 100 mg three times daily as needed.

FDA indications/Dosages for Phenergan with Codeine

For the temporary relief of coughs and upper respiratory symptoms associated with allergies or the common cold. Recommended dose is 1 teaspoon (5mL) every 4-6 hrs.

FDA indications/Dosages for Codeine Phosphate w/ Guaifenesin

For the temporary relief of cough due to minor throat and bronchial irritation associated with the common cold or inhaled irritants. Take 1-2 teaspoonfuls every 4-6 hrs, not to exceed 12 teaspoons in 24 hrs

FDA indications/Dosages for Fluticasone Furoate, Umeclidinium Bromide, and Vilanterol

For maintenance treatment of asthma in patients older than 18, and for treatment of COPD. Recommended dose is 1 inhalation once daily.

FDA indications/Dosages for Breo Ellipta

For the long-term, once-daily maintenance treatment of airflow obstruction in patients with COPD, to reduce the exacerbations of COPD in patients with a history of exacerbations, and for the treatment of asthma in patients aged 18 or older. Recommended dose is 1 inhalation of the 100/25 inhaler once daily.

FDA indications/Dosages for Budesonide and Formoterol Fumarate Dihydrate

For the treatment of asthma in patients 12 years of age and older, and for the maintenance treatment of airflow obstruction in patients with COPD. Recommended dose is 2 inhalations twice daily.

FDA indications/Dosages for Anoro Ellipta

For the long term, once-daily, maintenance treatment of airflow obstruction in patients with COPD. Recommended dose is 1 inhalation once daily.

FDA indications/Dosages for Umeclidinium Bromide

For the maintenance treatment of COPD including chronic bronchitis/emphysema. Recommended dose is one inhalation daily given at the same time everyday.

FDA indications/Dosages for Brovana

For the long-term maintenance treatment of bronchostriction in patients with COPD including chronic bronchitis/emphysema. Recommended dose is 1 vial (15 mcg) twice a day

FDA indications/Dosages for Pulmicort

For the maintenance treatment of asthma and as a prophylactic therapy in children 12 months- 8 years of age, and for the maintenance treatment of asthma and as prophylactic therapy in adults and pediatric patients. Recommended dose is 180mcg (children) or 360 mcg (adults) twice a day.

FDA indications/Dosages for Flovent

For the maintenance treatment of asthma as prophylactic therapy. Normal dose is 2 puffs of the 110 or 220 MDI twice a day or one inhalation of the 100 or 250 mcg diskus twice a day

FDA indications/Dosages for Diphenoxylate HCl w/ Atropine

Adjunct management of diarrhea. Recommended dose is two tablets/two teaspoonfuls of liquid four times a day until diarrhea is under control.

FDA indications/Dosages for Fiorecet

Relief of the symptom complex of tension (or muscle contraction) headache. Recommended dose is 1-2 tabs/capsules every 4 hrs as needed

FDA indications/Dosages for Ultram

For the management of moderate-moderately severe pain, and moderate-moderately severe pain in patients who require around the clock treatment. Give 50-100 mg as needed for the relief of pain every 4-6 hrs not to exceed 400 mg per day.

FDA indications/Dosages for Metoclopramide HCl

For the treatment of diabetic gastroparesis, prevention of nausea/vomiting associated with cancer chemotherapy, relief of symptomatic gastroesophageal reflux, and to facilitate small bowel intubation. Recommended dose is 5-10 mg taken 30 mins before each meal and at bedtime for 2-8 weeks.

FDA indications/Dosages for Ondansetron HCl

For the prevention of nausea and vomiting associated with chemotherapy, radiotherapy, and pre/post-operative nausea. Recommended dose is 8 mg given three times daily.

FDA indications/Dosages for Phenergan

For the management of perennial and seasonal allergies/allergic reactions, control of motion sickness, control of nausea and vomiting, and for sedation. Recommended dose is 12.5-25 mg every 4-6 hrs as needed.

FDA indications/Dosages for Sarafem

For the treatment of depression, OCD, bulimia nervosa, and panic disorder with/without agoraphobia. Recommended dose range is 10-40 mg

FDA indications/Dosages for Venlafaxine HCl

For the treatment of depression, generalized anxiety disorder, and social anxiety disorder. Start with 75 mg/day administered in a single dose (XR) or 2-3 divided doses (tablets) taken with food.

FDA indications/Dosages for Zyban

For the treatment of depression and for the prevention of seasonal major depressive episodes in patients with SAD, aids in smoking cessation. Recommended dose is 150-300 mg given once per day.

FDA indications/Dosages for Citalopram HBr

For the treatment of depression. Begin with a dose of 20 mg given once daily.

FDA indications/Dosages for Duloxetine HCl

For the treatment of major depressive disorder (MDD), management of neuropathic pain associated with diabetes, treatment of generalized anxiety disorder (GAD), and for the management of chronic musculoskeletal pain. The normal total daily dose is 40-60 mg.

FDA indications/Dosages for Nortriptyline HCLl

For the treatment of depression. Recommended dose is 75-150 mg given daily in a single or multiple doses

FDA indications/Dosages for Remeron

Indicated for the treatment of depression. Maintenance dosage range is 15-45 mg per day

FDA indications/Dosages for Elavil

For the relief of the symptoms of depression. Recommended dose is 40-150 mg per day in divided doses or at bedtime

FDA indications/Dosages for Vilazodone HCl

For the treatment of major depressive disorder. Usually daily dose is 40 mg once daily given with food

FDA indications/Dosages for Paxeva

For the treatment of depression, OCD, treatment of depression in the elderely/debilitated patients, Treatment of panic disorder, social anxiety disorder, and premenstrual dysphoric disorder. Maintenance dosage range is 25- 62.5 mg daily

FDA indications/Dosages for Vortioxetine

For the treatment of major depressive disorder (MDD) in adults. Recommended starting dose is 10 mg given once daily without regard to meals.

FDA indications/Dosages for Pristiq

For the treatment of major depressive disorder (MDD). Recommended dose is 50 mg once daily, with or without food.

FDA indications/Dosages for Doxepin HCl

For the treatment of psychoneurotic patients with depression and or anxiety, depression associated with alcoholism, depression associated with organic disease, psychotic depressive disorders, and treatment of insomnia. Recommended dose is 75-150 mg per day

FDA indications/Dosages for Semaglutide

As an adjunct to a reduced calorie diet and increased physical activity for chronic weight management in adults that have a BMI over 30 kg/m2. Maintenance dose is 2.4 mg once weekly

FDA indications/Dosages for Phentermine HCl

As a short-term adjunct in a regimen of weight reduction based on exercise, behavioral modification, and caloric reduction in the management of exogenous obesity. The usual adult dose is 1 tab/capsule taken before breakfast or 1-2 hrs after breakfast.

FDA indications/Dosages for Nystop

For the topical treatment of cutaneous/mucocutaneous mycotic infections caused by a variety of the Candida species. Apply liberally to the infected area 2-3 times a day

FDA indications/Dosages for Terbinafine HCl

For the oral treatment of onychomycosis of the toenail/fingernail, treatment of athlete's foot, ringworm, jock itch. For the topical treatment of planta tinea pedis (athletes foot), and various fungal infections of the skin (tinea versicolor). Recommended dose is one 250 mg tablet daily for 6 weeks in patients with fingernail infections, and 12 weeks for toenail infections.

FDA indications/Dosages for Ketoconazole

Treatment of systemic fungal infections, tinea corporis/tinea cruris, seborrheic dermatitis, and reduction of scaling due to dandruff. Apply twice daily for 4 weeks or until clinical clearing.

FDA indications/Dosages for Diflucan

For the treatment of vaginal candidiasis, esophageal candidiasis, systemic candidiasis, and cryptococcal meningitis. Recommended dose is 150 mg as a single oral dose

FDA indications/Dosages for Vimpat

Treatment of partial-onset seizures in patients 4 years and older. Recommended dose is 100 mg given twice daily initally.

FDA indications/Dosages for Phenobarbital

For sedation, hypnosis, preoperative sedation (in kids), and convulsive disorders. Recommended dose is 30-120 mg daily in 2-3 divided doses

FDA indications/Dosages for Carbamazepine

Treatment of various types of seizure disorders, and management of trigeminal neuralgia pain. Maintenance dose is 800-1200 mg per day in 3-4 divided doses, using the minimum effective dose

FDA indications/Dosages for Keppra

For adjunctive treatment of partial onset seizures with/without generalization in juvenile myoclonic epilepsy and in primary generalized tonic-clonic seizures. Start with a daily dose of 1000 mg, given twice daily

FDA indications/Dosages for Depakote ER

Treatment of simple, complex absence, and complex partial seizures, treatment of acute mania/mixed episodes associated with bipolar disorder, and for the prophylaxis of migraine headaches. Recommended dose is 250 mg three times daily or 25 mg/kg of ER tablets given once daily.

FDA indications/Dosages for Lyrica

For the treatment of neuropathic pain associated with diabetes, postherpetic neuralgia, adjunctive therapy for adult patients with partial onset seizures, and for the treatment of fibromyalgia. Begin with a dose at 75 mg twice daily or 50 mg three times daily (150 mg/day)

FDA indications/Dosages for Phenytoin (extended)

For the control of tonic-clonic, psychomotor seizures and prevention/treatment of seizures during/after neurosurgery. Recommended dose is 100 mg three times daily or 300 mg once daily.

FDA indications/Dosages for Mysoline

For the control of grand mal, psychomotor/focal epileptic seizures either alone or with other anticonvulsants. Maintenance dose is 250 mg 3-4 times daily

FDA indications/Dosages for Topamax

As adjunctive and monotherapy for adults and pediatric patients ages 2-16 with partial onset seizures, primary generalized tonic-clonic seizures, and those associated with Lennox-Gastaut syndrome, for the prophylaxis of migraine headaches. Recommended dose for adjunctive therapy is 200-400 mg

FDA indications/Dosages for Oxtellar XR

For use as monotherapy or adjunctive therapy in the treatment of partial seizures in adults and children 4-16 years with epilepsy. Start with 300 mg given twice daily

FDA indications/Dosages for Lamotrigine

As adjunctive therapy in pediatric/adult patients with partial seizures, generalized seizures of Lennox-Gastaut syndrome, maintenance of bipolar I disorder to delay time to mood episode reoccurrences. Normal dose range is 25-200 mg once daily.

FDA indications/Dosages for Insulin Glargine

Indicated for once daily subcutaneous administration at bedtime in the treatment of adult and pediatric patients with type 1 diabetes or in adults with type 2 diabetes who require long acting insulin for hyperglycemia. Dosage must be individualized